




Healthcare Industry News: Camber Spine Technologies
News Release - January 23, 2017
Camber Spine Technologies Announces 510(k) Clearance For Their Siconus(TM) SI Joint Fixation System
WAYNE, Pa., Jan. 23, 2017 -- (Healthcare Sales & Marketing Network) -- Camber Spine Technologies, today announced that it has received 510(k) clearance for their Siconus™ SI Joint Fixation System. Siconus™ becomes the second product in the Camber Spine Technologies portfolio to treat sacroiliac disease, as a complement to the Prolix™ custom machined allograft implant.The Siconus™ SI Fixation System is intended to provide fixation and stabilization of large bones, including the sacrum and ilium. It is intended for use in skeletally mature patients as an adjunct to sacroiliac joint fusion in the treatment of the degenerative sacroiliitis, or sacroiliac joint disruptions.
Siconus™ was developed under a collaborative agreement with the Institute for Musculoskeletal Science & Education (IMSE), an independent, full-service product development and engineering services company.
About Camber Spine
Camber Spine Technologies, LLP, is a fast-growing musculoskeletal implant company founded in 2010 bringing innovative, best-in-class products to the market, providing surgeons and their patients with better treatment options. The company is committed to delivering surgeon inspired new technologies to the spine market. Camber is an ISO 13485 certified medical device company. Camber Spine Technologies, located in Wayne, Pennsylvania, markets a line of proprietary musculoskeletal products nationwide through its exclusive distributor, S1 Spine. For further information please visit www.cambermedtech.com. For inquiries about Siconus™ or distribution opportunities please call 484.427.7060.
All of Camber Spine Technologies' products are proudly MADE IN THE USA.
Source: Camber Spine Technologies
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.